2[1]Podratz KC, Mariani A, Webb MJ. Staging and therapeutic value of lymphadenectomy in endometrial cancer[J ]. Gynecol Oncol, 1998,70 (2):163 - 164.
3[2]Ehrlich CE,Young PC,Stehman FB,et al.Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium [J ].Am J Obstet Gynecol, 1988,158(4) :796 - 807.
4[3]Pisani AL,Barbuto DA,Chen D,et al. HER-2/neu,p53,and DNA anal yses as prognosticators for survival in endometrial carcinoma[J ]. Obstet Gynecol, 1995,85 (5 Pt 1 ) :729 - 734.
5[4]Morris PC, Anderson JR, Anderson B, et al. Steroid hormone receptor content and lymph node status in endometrial cancer[J ]. Gynecol On col, 1995,56(3) :406 - 411.
6[5]lwai K, Fukuda K, Hachisuga T, et al. Prognostic significance of pro gesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma[J]. Gynecol Oncol, 1999,72(3) :351 - 359.
